XORTX Therapeutics Inc. (XRTX) — Institutional Holders, Q2 2026
6 institutional investment managers reported a XRTX position on SEC Form 13F-HR for the quarter ended June 30, 2026, with a combined reported value of $92.8K. Every filer is listed below, ranked by position value. Put and call option positions are excluded, and a firm filing several lots or share classes is shown once with its total.
XRTX in Q2 2026: what funds did
Funds that filed a 13F for both Q1 2026 and Q2 2026, by what they did with the common stock. Share counts are adjusted for any split between the two quarters; dollar figures are the change in shares at this quarter’s price.
Biggest buyers
- CITADEL ADVISORSNew · +23,116 sh+$52.5K
- StoneX GroupNew · +16,369 sh+$37.2K
- ROYAL BANK OF CANADANew · +732 sh+$1.7K
- NATIONAL BANK OF CANADANew · +162 sh+$368.00
Biggest sellers
- Kingsview Wealth ManagementSold out · -3,000 sh-$6.8K
XRTX 13F holders ranked 1–6 of 6
| # | Institution | Shares | Value | % of portfolio | QoQShares vs Q1 2026 |
|---|---|---|---|---|---|
| 1 | CITADEL ADVISORS#1 · 23,116 sh | 23,116 | $52.5K | 0.00% | New |
| 2 | StoneX Group#2 · 16,369 sh | 16,369 | $37.9K | <0.01% | New |
| 3 | ROYAL BANK OF CANADA#3 · 732 sh | 732 | $2.0K | 0.00% | New |
| 4 | NATIONAL BANK OF CANADA#4 · 162 sh | 162 | $329.00 | 0.00% | New |
| 5 | Clearstead Advisors#5 · 55 sh | 55 | $120.00 | 0.00% | -80.1% |
| 6 | TD Waterhouse Canada#6 · 9 sh | 9 | $19.00 | — | -80.9% |
Funds that sold out of XRTX in Q2 2026 (1)
Held XRTX at the end of Q1 2026 and filed a Q2 2026 13F without it. Not in the list above, because they no longer hold it. Largest prior position first.
| Institution | Shares sold | Value in Q1 2026 |
|---|---|---|
| Kingsview Wealth Management3,000 sh | 3,000 | $6.1K |
Source: Form 13F-HR filings on SEC EDGAR, Q2 2026. Values are as reported by each manager at quarter end. “% of portfolio” is the position’s share of the manager’s total reported 13F value for the same quarter. “New” means the manager filed a 13F for Q1 2026 without this position; a dash means no comparison is available. Where a manager’s own filing is internally inconsistent its value is withheld and it is listed last. 13F data shows reported holdings, not recommendations.